These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9816129)
1. Expression of the Mr 67,000 laminin receptor is an adverse prognostic indicator in human thyroid cancer: an immunohistochemical study. Basolo F; Pollina L; Pacini F; Fontanini G; Ménard S; Castronovo V; Bevilacqua G Clin Cancer Res; 1996 Oct; 2(10):1777-80. PubMed ID: 9816129 [TBL] [Abstract][Full Text] [Related]
2. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. Fernández PL; Merino MJ; Gómez M; Campo E; Medina T; Castronovo V; Sanjuán X; Cardesa A; Liu FT; Sobel ME J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007 [TBL] [Abstract][Full Text] [Related]
3. uPA receptor expression in benign and malignant thyroid tumors. Kim SJ; Shiba E; Taguchi T; Tsukamoto F; Miyoshi Y; Tanji Y; Takai S; Noguchi S Anticancer Res; 2002; 22(1A):387-93. PubMed ID: 12017319 [TBL] [Abstract][Full Text] [Related]
4. Reciprocal immunohistochemical expression of sodium/iodide symporter and hexokinase I in primary thyroid tumors with synchronous cervical metastasis. Jung YH; Hah JH; Sung MW; Kim KH; Cho SY; Jeon YK Laryngoscope; 2009 Mar; 119(3):541-8. PubMed ID: 19235753 [TBL] [Abstract][Full Text] [Related]
5. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis. Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122 [TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study on the prognostic value of the expression of laminin and Ki-67 receptors in advanced gastric cancer]. de Manzoni G; Guglielmi A; Di Leo A; Tomezzoli A; Laterza E; Bonfiglio M; Biolo S; Tedesco P; Borzellino G G Chir; 1998; 19(8-9):323-8. PubMed ID: 9734182 [TBL] [Abstract][Full Text] [Related]
7. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria]. Schröder S Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226 [TBL] [Abstract][Full Text] [Related]
8. Maspin in thyroid cancer: its relationship with p53 and clinical outcome. Boltze C; Schneider-Stock R; Meyer F; Peters B; Quednow C; Hoang-Vu C; Roessner A Oncol Rep; 2003; 10(6):1783-7. PubMed ID: 14534696 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities. Reich R; Vintman L; Nielsen S; Kaern J; Bedrossian C; Berner A; Davidson B Diagn Cytopathol; 2005 Nov; 33(5):332-7. PubMed ID: 16240397 [TBL] [Abstract][Full Text] [Related]
10. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features. Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744 [TBL] [Abstract][Full Text] [Related]
11. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421 [TBL] [Abstract][Full Text] [Related]
12. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490 [TBL] [Abstract][Full Text] [Related]
13. 67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas. Fontanini G; Vignati S; Chiné S; Lucchi M; Mussi A; Angeletti CA; Ménard S; Castronovo V; Bevilacqua G Clin Cancer Res; 1997 Feb; 3(2):227-31. PubMed ID: 9815677 [TBL] [Abstract][Full Text] [Related]
14. Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma. Weinberger PM; Adam BL; Gourin CG; Moretz WH; Bollag RJ; Wang BY; Liu Z; Lee JR; Terris DJ Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):503-10. PubMed ID: 17515507 [TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of vascular endothelial growth factor for thyroid neoplasms. Huang SM; Lee JC; Wu TJ; Chow NH World J Surg; 2001 Mar; 25(3):302-6. PubMed ID: 11343180 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer. Chakravarty G; Santillan AA; Galer C; Adams HP; El-Naggar AK; Jasser SA; Mohsin S; Mondal D; Clayman GL; Myers JN Exp Biol Med (Maywood); 2009 Apr; 234(4):372-86. PubMed ID: 19176870 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. von Wasielewski R; Rhein A; Werner M; Scheumann GF; Dralle H; Pötter E; Brabant G; Georgii A Cancer Res; 1997 Jun; 57(12):2501-7. PubMed ID: 9192832 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of CXCR4 in thyroid carcinomas and thyroid benign lesions. He X; Wei Q; Zhang X; Xiao J; Jin X; Zhu Y; Cui B; Ning G Pathol Res Pract; 2010 Oct; 206(10):712-5. PubMed ID: 20646838 [TBL] [Abstract][Full Text] [Related]